Fig. 6From: Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)Longitudinal changes of serum Gal-9 or sTIM-3 concentrations in 7 patients with IgG4-RD before and after glucocorticoid therapy. a–c Gal-9, sTIM-3, and IgG4 concentrations in IgG4-RD patients were not significantly different between before and after treatment. d IgG4 responder index was significantly decreased after glucocorticoid therapy. Paired samples from the same subjects were compared by the Wilcoxon signed-rank testBack to article page